Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.

@article{Perrillo1999MulticenterSO,
  title={Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.},
  author={Robert P. Perrillo and Jorge Rakela and J Dienstag and G. Levy and Paul Martin and Teresa Wright and Stuart Caldwell and Eugene R Schiff and Robert R Gish and J P Villeneuve and Gist Farr and Gaya C Anschuetz and Lynette Crowther and Nathaniel F. Brown},
  journal={Hepatology},
  year={1999},
  volume={29 5},
  pages={1581-6}
}
Hepatitis B after liver transplantation is often fatal, and no proven medical therapy exists for this condition. We chose to study the potential efficacy of lamivudine therapy for patients with chronic hepatitis B after liver transplantation. Fifty-two patients with chronic hepatitis B after liver transplantation were treated in an open label, multicenter study. Each had detectable hepatitis B virus (HBV) DNA in serum and 45 (87%) had detectable serum hepatitis B e antigen before treatment… CONTINUE READING
50 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 50 extracted citations

Similar Papers

Loading similar papers…